Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: A possible step in peritoneal metastasis

Clinical and Experimental Metastasis

Volumn 14, Issue 4, 1996, Pages 325-334

  Gardner, M J ^a   Catterall, J B ^a   Jones, L M H ^a   Turner, G A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

CD44; Cell adhesion; Hyaluronic acid; Invasion; Mesothelial cells; Metastasis; Ovarian tumour cells

Indexed keywords

CELL ADHESION MOLECULE; HERMES ANTIGEN; HYALURONIC ACID;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; HUMAN; HUMAN CELL; OVARY CARCINOMA; PERITONEUM METASTASIS;

ANTIBODIES; ANTIGENS, CD44; AUTORADIOGRAPHY; CELL ADHESION; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS; FEMALE; FLUOROMETRY; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029960696     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00123391     Document Type: Article

References (30)

1. Surveys, Office of Population Censuses and Surveys, 1994. Cancer Statistics 1989, HMSO.
2. Hoskins WJ, 1993, Surgical staging and cytoreductive surgery of epithelial ovarian cancer. Cancer, 71, 1534-40.
3. Fox H, 1990, Pathology of ovarian cancer. In: Shepherd J and Monaghan J, eds. Clinical Gynaecological Cancer. Oxford: Blackwell Scientific Publishers, pp. 188-217.
4. Lesley J, Hyman R, and Kinkade PW, 1993, CD44 and its interaction with extracellular matrix. Adv in Immunol, 54, 271-335.
5. Catterall JB, Gardner MJ and Turner GA, 1995. Hyaluronic acid, cell adhesion and metastasis. The Cancer J, 8, 320-4.
6. Guo YJ, Ma J, Wang JH, et al., 1994. Inhibition of human-melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res, 54, 1561-5.
7. Sy MS, Guo YJ and Stamenkovic I, 1991, Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med, 174, 859-66.
8. Sy MS, Guo YJ and Stamenkovic I, 1992, Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J Exp Med, 176, 623-7.
9. Sleeman J, Moll J, Sherman L, et al., 1995, The role of CD44 splice variants in human metastatic cancer. Ciba Foundation Symposium, 189, 142-56.
10. Knudson W, Biswas C and Toole BP, 1984, Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. Proc Natl Acad Sci. 81, 6767-71.
11. Toole BP, Biswas C and Gross J, 1979, Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc Natl Acad Sci, 76, 6299-303.
12. Turley EA, Austen K, Vandeligt K and Clarey C, 1991, Hyaluronan and cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J Cell Biol, 112, 1041-7.
13. Rooney P, Kumar S, Ponting J and Wang M, 1995, The role of hyaluronan in tumour neovascularization. Int J Cancer, 60, 632-6.
14. Gardner MJ, Jones LMH, Catterall JB and Turner GA, 1995, Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis. Cancer Lett, 91, 229-34.
15. Jones LMH, Gardner JB, Catterall JB and Turner GA, 1995, Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion. Clin Exp Metastasis, 13, 373-80.
16. Hills CA, Kelland LR, Abel G, Sirachy J, Wilson AP and Harrap KR, 1989, Biological properties of ten human ovarian caricinoma cell lines: calibration in vitro against four platinium complexes. Br J Cancer, 59, 527-34.
17. Mobus V, Gerharz CD, Press V, et al., 1992, Morphological, immunological, histochemical and biochemical characterisation of 6 newly established human ovarian tumour carcinoma cell lines. Int J Cancer, 52, 76-84.
18. Catterall JB, Gardner MJ, Jones LMH and Turner GA, 1994, A precise, rapid and sensitive in vitro assay to measure the adhesion of ovarian tumour cells to peritoneal mesothelial cells. Cancer Lett, 87, 199-203.
19. Stern P, Gilbert P, Sternberg S, Thompson S, Chada K, 1984, A monoclonal antibody which detects a 125kD glycoprotein on embryonal carcinoma cells and is mitogenic for murine spleen cells. J Reprod Immunol, 6, 313-28.
20. Cannistra SA, Kansas GS, Niloff J, Defranzo B, Kim Y and Ottensmeier C, 1993, Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res, 53, 3830-8.
21. Lee JH, Kang Y-S, Kim B-G, et al, 1995, Expression of the CD44 adhesion molecule in primary and metastatic gynecologic malignancies and their cell lines. Int J Gynecol Cancer, 5, 193-9.
22. Cannistra SA, Abu-Jawdeh G, Niloff J, et al., 1995, CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors. J Clin Oncol, 13, 1912-21.
23. Fox SB, Fawcett J, Jackson DG, et al., 1994, Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res, 54, 4539-46.
24. Anstee DJ, Gardner B, Spring FA, et al., 1991, New monoclonal antibodies in CD44 and CD58: their use to quantify CD44 and CD58 on normal human erythrocytes and to compare the distribution of CD44 and CD58 in human tissues. Immunol, 74, 197-205.
25. Belitsos PC, Hildreth JEK and August JT, 1990, Homotypic cell aggregation induced by anti-CD44 (Pgp-1) monoclonal antibodies and related to CD44 (Pgp-1) expression. J Immunol, 144, 1661-70.
26. Culty M, Miyake K, Kincade PW, et al., 1990, The hyaluronan receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol, 111, 2765-74.
27. East JA, Mitchell SD and Hart IR, 1993, Expression and function of the CD44 glycoprotein in melanoma cell lines. Melanoma Res, 3, 341-6.
28. Bennett KL, Modrell B, Greenfield B, et al., 1995, Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol, 131, 1623-33.
29. Lesley J, English N, Perschl A, Gregoroff J and Hyman R, 1995, Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med, 182, 431-7.
30. Katoh S, Zheng Z, Oritani K, Shimozato T and Kinkade PW, 1995, Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med, 182, 419-29.